FDA Guides On Bioequivalence Studies And COVID-19
Offers Advice On Protecting Participants In Studies For ANDAs
Guidance on protecting participants in bioequivalence studies during the COVID-19 pandemic has been published by the FDA.
Guidance on protecting participants in bioequivalence studies during the COVID-19 pandemic has been published by the FDA.